UBS Group’s NeuroSense Therapeutics Ltd. Warrant NRSNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932 | Sell |
1,470
-1,371
| -48% | -$869 | ﹤0.01% | 8377 |
|
|
2025
Q1 | $582 | Buy |
2,841
+2,747
| +2,922% | +$563 | ﹤0.01% | 8406 |
|
|
2024
Q4 | $41 | Sell |
94
-106
| -53% | -$46 | ﹤0.01% | 8476 |
|
|
2024
Q3 | $28 | Sell |
200
-405
| -67% | -$57 | ﹤0.01% | 8066 |
|
|
2024
Q2 | $125 | Buy |
+605
| New | +$125 | ﹤0.01% | 7966 |
|
|
2023
Q4 | – | Sell |
-3,802
| Closed | -$422 | – | 8412 |
|
|
2023
Q3 | $422 | Buy |
+3,802
| New | +$422 | ﹤0.01% | 7359 |
|
|
2023
Q1 | – | Sell |
-798
| Closed | -$128 | – | 8837 |
|
|
2022
Q4 | $128 | Sell |
798
-1,160
| -59% | -$186 | ﹤0.01% | 9168 |
|
|
2022
Q3 | $0 | Buy |
+1,958
| New | – | ﹤0.01% | 9522 |
|
|
2022
Q1 | – | Sell |
-4,491
| Closed | -$4K | – | 9457 |
|
|
2021
Q4 | $4K | Buy |
+4,491
| New | +$4K | ﹤0.01% | 8407 |
|